»ó´Ü¿©¹é
±â»ç (Àüü 976°Ç)
[Sub Story] Ç︮ÄÚ¹ÚÅÍ Á¦±ÕÄ¡·á Ç×»ýÁ¦¿¡¼­ P-CAB±îÁö ÀÓ¼¼Çü ±âÀÚ 2021-01-22 13:15
[Sub Story] ¼ÒÈ­ºÒ·®Áõ Áø´Ü ¶§ºÎÅÍ À§¾Ï ¿©ºÎÈ®ÀÎ °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 12:00
[Interview] ¡°¼ÒÈ­ºÒ·® ¾ÆÇü Áß½É Ä¡·áÀü·« Á¦½Ã¡± ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:56
[Sub Story] C.difficile °íÀ§Ç豺¿¡ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ±Ç°í ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:51
[Drug Review] ¡®±Ù°Å ±â¹Ý¡¯ ÇÁ·Î¹ÙÀÌ¿Àƽ½º·Î ³ª°¡´Â Áß ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:45
¶óÀÎ
[Sub Story] ¾Æ½ºÇǸ° + Ç×Ç÷¼ÒÆÇÁ¦ ¼ÒÈ­¼º±Ë¾ç À§Çè¡è ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:38
[Sub Story] DAA-µ¿¹ÝÁúȯ ¾àÁ¦ °£ »óÈ£ÀÛ¿ë °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:33
[Sub Story] À¯ÀüÀÚÇü¡¤Ä¡·áº´·Â¡¤°£°æº¯Áõ È®ÀÎ °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:23
[Sub Story] HBV ¾àÁ¦³»¼º¡¤ÀçÈ°¼ºÈ­ °ü¸®¿¡ ¹«°Ô ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:18
[Conference Report] °£¿° °ü¸®, °£¾Ï À§Çè °¨¼Ò·Î Á÷°á ÀÓ¼¼Çü ±âÀÚ 2021-01-22 11:04
¶óÀÎ
[Conference Report] CÇü°£¿° Ä¡·áÅëÇÑ °£¾Ï À§Çè °¨¼Ò È®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:57
[Interview] ¡°°íÀ§Çè CAD¿¡¼­ ACEI ÀÔÁö È®ÀÎÇß´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:53
[Drug Review] ´Ã¾î³ª´Â NSAIDs ¼ÒÈ­¼º±Ë¾ç ¿¹¹æ ´ë¾È ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:45
[Conference Report] ¸¸¼º BÇü°£¿° Ä¡·áÀü·« ¾÷µ¥ÀÌÆ® ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:39
[Conference Report] Áö¹æ°£ ¹× °£¼¶À¯È­Áõ Ä¡·áÀü·« ÀÓ¼¼Çü ±âÀÚ 2021-01-22 10:34
¶óÀÎ
[Deep in Guideline] LDL-C °í°­µµ °­ÇÏÀü·« ±âÁ¶ À¯Áö ÀÓ¼¼Çü ±âÀÚ 2021-01-04 18:45
[Interview] ¡°°æ±¸¿ë º¹ÇÕÁ¦, ¼øÀÀµµÀÇ ¡®Çٽɡ¯ µÉ ¼ö ÀÖ´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2021-01-04 18:45
[Sub Story] Àû¿ë¹üÀ§ ³ÐÇô°¡´Â ICS/LABA ÀÓ¼¼Çü ±âÀÚ 2021-01-04 18:44
[Sub Story] DAT¡¤TAT ½Ã´ë ±Ù°Å°¡ ¸»ÇÏ´Â Àü·«Àº? ÀÓ¼¼Çü ±âÀÚ 2021-01-04 18:44
[Sub Story] Ç÷¼ÒÆÇ ±â´É°ú ÀÀ°íÀÛ¿ë ¸·¾Æ Ç÷Àü »ý¼º ¿¹¹æ ÀÓ¼¼Çü ±âÀÚ 2021-01-04 17:17
Back to Top